137 related articles for article (PubMed ID: 23897585)
21. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
22. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma.
Cook NR; Stampfer MJ; Ma J; Manson JE; Sacks FM; Buring JE; Hennekens CH
Cancer; 1999 Nov; 86(9):1783-92. PubMed ID: 10547552
[TBL] [Abstract][Full Text] [Related]
23. Plasma sphingolipids and lung cancer: a population-based, nested case-control study.
Alberg AJ; Armeson K; Pierce JS; Bielawski J; Bielawska A; Visvanathan K; Hill EG; Ogretmen B
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1374-82. PubMed ID: 23749868
[TBL] [Abstract][Full Text] [Related]
24. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
26. Drugs for preventing lung cancer in healthy people.
Caraballoso M; Sacristan M; Serra C; Bonfill X
Cochrane Database Syst Rev; 2003; (2):CD002141. PubMed ID: 12804424
[TBL] [Abstract][Full Text] [Related]
27. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
28. Elevated serum pro-mMP2 levels in patients with advanced lung cancer are not suitable as a prognostic marker.
Sasaki H; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Surg Today; 2002; 32(1):93-5. PubMed ID: 11871828
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein and risk of lung cancer.
Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
[TBL] [Abstract][Full Text] [Related]
30. Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.
He Y; Gong Y; Lin J; Chang DW; Gu J; Roth JA; Wu X
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):443-51. PubMed ID: 23300022
[TBL] [Abstract][Full Text] [Related]
31. Ras p21 protein levels in human plasma from patients with chronic obstructive pulmonary disease (COPD) compared with lung cancer patients and healthy controls.
Anderson D; Hughes JA; Cebulska-Wasilewska A; Nizankowska E; Graca B
Mutat Res; 1998 Jul; 403(1-2):229-35. PubMed ID: 9726023
[TBL] [Abstract][Full Text] [Related]
32. Retinol and retinol-binding protein in lung cancer screening.
Edes TE; McDonald PS
Cancer Detect Prev; 1991; 15(5):341-4. PubMed ID: 1751943
[TBL] [Abstract][Full Text] [Related]
33. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
34. Blood cadmium levels as a marker for early lung cancer detection.
Lener MR; Reszka E; Marciniak W; Lesicka M; Baszuk P; Jabłońska E; Białkowska K; Muszyńska M; Pietrzak S; Derkacz R; Grodzki T; Wójcik J; Wojtyś M; Dębniak T; Cybulski C; Gronwald J; Kubisa B; Pieróg J; Waloszczyk P; Scott RJ; Jakubowska A; Narod SA; Lubiński J
J Trace Elem Med Biol; 2021 Mar; 64():126682. PubMed ID: 33249371
[TBL] [Abstract][Full Text] [Related]
35. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
36. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer.
Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y
Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209
[TBL] [Abstract][Full Text] [Related]
37. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
38. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
[TBL] [Abstract][Full Text] [Related]
39. Relationship of serum cholesterol, dietary and plasma beta-carotene with lung cancer in male smokers.
Scali J; Astre C; Segala C; Gerber M
Eur J Cancer Prev; 1995 Apr; 4(2):169-74. PubMed ID: 7767243
[TBL] [Abstract][Full Text] [Related]
40. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
